View in EDS HTML Full Text PDF Full Text

IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension.

Saved in:
Bibliographic Details
Title: IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension.
Authors: Gillies, Hunter1 (AUTHOR) hgillies@aerovatetx.com, Chakinala, Murali M.2 (AUTHOR), Dake, Benjamin T.1 (AUTHOR), Feldman, Jeremy P.3 (AUTHOR), Hoeper, Marius M.4,5 (AUTHOR), Humbert, Marc6 (AUTHOR), Jing, Zhi‐Cheng7 (AUTHOR), Langley, Jonathan1 (AUTHOR), McLaughlin, Vallerie V.8 (AUTHOR), Niven, Ralph W.1 (AUTHOR), Rosenkranz, Stephan9 (AUTHOR), Zhang, Xiaosha1 (AUTHOR), Hill, Nicholas S.10 (AUTHOR)
Source: Pulmonary Circulation. Jan2024, Vol. 14 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20458932
DOI:10.1002/pul2.12352